.Novo Nordisk is actually continuing its own push into hereditary medications, agreeing to pay NanoV...
.Innovent Biologics has actually produced the scenario that its own checkpoint inhibitor-cytokine bl...
.A period 3 test of Daiichi Sankyo and also Merck & Co.'s HER3-directed antibody-drug conjugate (...
.Five months after Rakovina Therapeutics pivoted towards artificial intelligence, the cancer-focused...
.Ascendis Pharma has emerged as a potential hazard to BioMarin's Voxzogo, disclosing phase 3 growth ...
.Though Alkeus Pharmaceuticals' oral eye condition property fell short to significantly lessen geogr...
.With a triad of biotechs reaching the Nasdaq on Friday, it was actually simple to miss a smaller-sc...
.Invulnerable gate inhibitors are the superheroes of cancer cells treatment. Medications like Bristo...
.Invite to today's Chutes & Ladders, our summary of substantial management hirings, firings and a...
.Regeneron is back along with lasting follow-up for its LAG-3 inhibitor and PD-1 inhibitor combinati...